United-Guardian logo

United-GuardianNASDAQ: UG

Profile

Country:

United States

IPO:

17 March 1980

Next earnings report:

09 August 2024

Last dividends:

09 February 2024

Next dividends:

N/A
$44.20 M
-62%vs. 3y high
26%vs. sector
-40%vs. 3y high
39%vs. sector
-63%vs. 3y high
78%vs. sector
-53%vs. 3y high
89%vs. sector

Price

after hours | Wed, 03 Jul 2024 20:30:43 GMT
$9.62+$0.31(+3.33%)
$3.25 M$925.40 K

Analysts recommendations

Institutional Ownership

UG Latest News

United-Guardian: A High-Risk/High-Reward Investment
Seeking Alpha07 July 2023 Sentiment: POSITIVE

Volumes are currently depressed due to a stronger dollar, a slow Chinese reopening, and customer destocking. The company is highly profitable as it has very high profit margins. The balance sheet is robust thanks to the absence of debt.

What type of business is United-Guardian?

United-Guardian, Inc. manufactures and markets cosmetic ingredients, pharmaceuticals, medical lubricants, and proprietary specialty industrial products in the United States and internationally. The company offers cosmetic ingredients, including LUBRAJEL line of water-based moisturizing and lubricating gel formulations; LUBRAJEL NATURAL consisting of natural ingredients for cosmetic use; LUBRAJEL MARINE; LUBRASIL II SB, a special formulation of LUBRAJEL in which silicone oil is incorporated into a LUBRAJEL base; LUBRAJEL II XD; B-122, a powdered lubricant that is used in the manufacture of pressed powders, eyeliners, rouges, and industrial products; KLENSOFT, a surfactant, which is used in shampoos, shower gels, makeup removers, and other cosmetic formulations; and ORCHID COMPLEX, an oil-soluble base for skin creams, lotions, cleansers, and other cosmetics. Its medical lubricants comprise LUBRAJEL RR and RC, which are water-based lubricant gels for urinary catheters; LUBRAJEL MG to lubricate urinary catheters, pre-lubricated enema tips, and other medical devices; LUBRAJEL LC and LUBRAJEL FA that are LUBRAJEL formulations for oral care; and LUBRAJEL FLUID to lubricate water-soluble products. The company's pharmaceutical products consist of RENACIDIN, a prescription drug to prevent and dissolve calcifications in urethral catheters and the urinary bladder; and CLORPACTIN WCS-90, an antimicrobial product to treat infections in the urinary bladder, and localized infections in the peritoneum, as well as eye, ear, nose and throat, and sinuses. Its industrial products include DESELEX, a sequestering and chelating agent used for manufacturing detergents; and THOROCLENS, a chlorine-based industrial cleanser. The company also conducts research and development primarily related to the development of cosmetic ingredients. It markets its products through marketing partners, distributors, and wholesalers. The company was founded in 1942 and is based in Hauppauge, New York.

What sector is United-Guardian in?

United-Guardian is in the Consumer Defensive sector

What industry is United-Guardian in?

United-Guardian is in the Household & Personal Products industry

What country is United-Guardian from?

United-Guardian is headquartered in United States

When did United-Guardian go public?

United-Guardian initial public offering (IPO) was on 17 March 1980

What is United-Guardian website?

https://www.u-g.com

Is United-Guardian in the S&P 500?

No, United-Guardian is not included in the S&P 500 index

Is United-Guardian in the NASDAQ 100?

No, United-Guardian is not included in the NASDAQ 100 index

Is United-Guardian in the Dow Jones?

No, United-Guardian is not included in the Dow Jones index

When does United-Guardian report earnings?

The next expected earnings date for United-Guardian is 09 August 2024